CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a highly sensitive diagnostic platform for detecting cancer biomarkers from blood samples. It focuses on point-of-care applications, allowing personalized follow-up of cancer treatment in local healthcare settings through an innovative technology that automates sample preparation and enables flexi…
Extremely high sensitivity is needed for the detection of cancer biomarkers during the follow-up of the treatment or post-operation period.
We have identified a novel technology that enables very sensitive detection of single-nucleotide polymorphism from blood, enabling point-of-care screening of liquid biopsies.
Our diagnostics platform will consist of new chemistry and device, and is an open system for designing new diagnostic targets.
This will enable customized follow-up of the cancer medic…
JYVASKYLAN YLIOPISTO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
